Cloud-Based Rare Disease Family Registry Market Study Highlights How Industry Demand Is Evolving

The cloud-based rare disease family registry market is poised for significant expansion in the coming years, driven by technological advancements and increasing focus on personalized healthcare. As rare disease research gains momentum, this market is set to play a crucial role in connecting patients, researchers, and clinicians through innovative digital platforms. Let's explore current market dynamics, major players, emerging trends, and the key segments shaping this sector.

Cloud-Based Rare Disease Family Registry Market Size and Growth Projections
The market for cloud-based rare disease family registries is projected to expand rapidly, reaching a value of $3.15 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 17.5%. Several factors contribute to this upward trajectory, including rising investments in orphan drug development, increasing demand for real-world evidence, broader precision medicine research, enhanced use of AI-powered data analytics, and a stronger focus on patient-centered research models. Key trends expected to dominate the market during this period include wider adoption of cloud-based patient registries, greater reliance on digital platforms for rare disease studies, deeper integration of genomic and clinical datasets, expansion of global clinical trial recruitment tools, and heightened attention to secure data sharing.

The cloud-based rare disease family registry market size has grown rapidly in recent years. It will grow from $1.4 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to growth of rare disease research initiatives, increasing patient advocacy involvement, expansion of clinical trial networks, rising adoption of electronic data capture tools, need for centralized patient data systems.

Download a free sample of the cloud-based rare disease family registry market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Players Leading the Cloud-Based Rare Disease Family Registry Market
This industry includes several influential companies such as Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, and Rare Central.
A noteworthy development occurred in May 2025, when US-based equity firm Vora Ventures acquired Hive Networks Inc. Although the financial details were undisclosed, this acquisition aims to broaden Hive Networks' influence by utilizing its cloud-based AI platform to foster collaboration, enhance data sharing, and improve patient outcomes in rare and chronic disease communities. Hive Networks Inc. specializes in providing a secure cloud infrastructure that enables patients, families, clinicians, and researchers to share data, insights, and best practices effectively.

Technological Advancements Creating New Opportunities in the Cloud-Based Rare Disease Registry Market
Innovative solutions such as bilingual federated registries are being introduced by leading companies to enhance data security and accessibility across multiple locations. These cloud-based systems allow patient data to remain stored locally while supporting multiple languages and adhering to regional privacy and consent regulations.
For example, in June 2025, the National Organization for Rare Disorders (NORD), a US nonprofit, announced plans to launch two Canadian patient registries for PKU and MPS. Developed together with Canadian advocacy groups, researchers, and healthcare providers, these registries are part of the IAMRARE Program's first implementation outside the United States. They are designed to comply with local consent requirements, facilitate cooperative real-time data collection and analysis, and accelerate research efforts to better understand rare metabolic disorders and enable clinical trial recruitment.

View the full cloud-based rare disease family registry market report:
https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Dominant Segments Within the Cloud-Based Rare Disease Family Registry Market
This market can be categorized by several key segments:
1) Component: Software and Services
2) Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud
3) Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, and Others
4) End-User: Hospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, Patient Advocacy Groups, and Other Users
Further breakdown includes:
- Software types such as Electronic Data Capture, Data Management Platforms, Analytics and Reporting Tools, Patient Engagement Tools, and Clinical Trial Management Systems
- Services covering Implementation and Integration, Training and Support, Data Hosting and Security, Consulting, and Maintenance and Upgrades

This comprehensive segmentation reflects the diverse needs and capabilities within the cloud-based rare disease family registry market, highlighting the varied ways stakeholders engage with and benefit from these innovative platforms.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.